Certara(us:CERT)

    10.69

    -0.19%

    Updated on 2024-12-23

    Open:10.71
    Close:10.69
    High:10.85
    Low:10.50
    Pre Close:10.71
    Volume:454119.00
    Amount:4.83M
    Turnover:0.28%
    Shares:160.99M
    MarketCap:1.72B
    DateTotalTotal SharesTotal RatioNewIncreasedDecreased
    2024-06-3023811985090574.50%2669112
    2024-03-3123311942789574.55%277891
    2023-12-3122711814656073.91%2876102
    2023-09-3022510665127566.72%2564112
    2023-06-3024210741683467.23%3479108
    2023-03-3122410762962567.43%388380
    2022-12-312249381175458.81%4067103
    2022-09-3020312050344175.42%446477
    dateorgNametotalratiochangeShareschangeRatio
    2024-06-30Blackrock Inc.134233808.34%-565446-4.04%
    2024-06-30Vanguard Group Inc124990327.77%-56348-0.45%
    2024-06-30Mubadala Investment Co Pjsc96153845.98%0
    2024-06-30Baillie Gifford & Co83573015.19%-180243-2.11%
    2024-06-30Wasatch Advisors Lp73648654.58%244002049.55%
    2024-06-30Geneva Capital Management Llc54728173.40%106861824.26%
    2024-06-30William Blair Investment Management, Llc52168883.24%-502902-8.79%
    2024-06-30Clearbridge Investments, Llc40873972.54%-85798-2.06%
    2024-06-30Jpmorgan Chase & Co40492952.52%-309850-7.11%
    2024-06-30State Street Corp35572882.21%-353-0.01%

    About

    Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.
    Address:4 Radnor Corporate Center,Suite 350

    Market Movers